S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
NASDAQ:CRVL

CorVel - CRVL Stock Forecast, Price & News

$158.94
+1.48 (+0.94%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$157.18
$162.00
50-Day Range
$131.96
$168.11
52-Week Range
$129.19
$213.38
Volume
53,473 shs
Average Volume
40,251 shs
Market Capitalization
$2.79 billion
P/E Ratio
43.31
Dividend Yield
N/A
Price Target
N/A

CorVel MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
3.12% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.11mentions of CorVel in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$10.73 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.48 out of 5 stars

Business Services Sector

356th out of 431 stocks

Insurance Agents, Brokers, & Service Industry

22nd out of 24 stocks

CRVL stock logo

About CorVel (NASDAQ:CRVL) Stock

CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.

Analyst Upgrades and Downgrades

Separately, TheStreet upgraded CorVel from a "c+" rating to a "b" rating in a research report on Friday, July 15th.

CorVel Stock Performance

Shares of CRVL Stock traded up $1.48 during mid-day trading on Monday, hitting $158.94. 53,473 shares of the stock traded hands, compared to its average volume of 42,346. The firm has a market cap of $2.79 billion, a price-to-earnings ratio of 43.31 and a beta of 0.95. The company's 50-day simple moving average is $149.44 and its 200-day simple moving average is $158.18. CorVel has a twelve month low of $129.19 and a twelve month high of $213.38.

CorVel (NASDAQ:CRVL - Get Rating) last issued its earnings results on Tuesday, August 2nd. The business services provider reported $0.94 earnings per share (EPS) for the quarter. The business had revenue of $176.31 million for the quarter. CorVel had a return on equity of 30.93% and a net margin of 9.89%.

Insider Buying and Selling

In related news, CFO Brandon O'brien sold 1,204 shares of CorVel stock in a transaction on Tuesday, June 14th. The stock was sold at an average price of $134.01, for a total value of $161,348.04. Following the transaction, the chief financial officer now directly owns 2,664 shares in the company, valued at approximately $357,002.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Brandon O'brien sold 1,204 shares of CorVel stock in a transaction on Tuesday, June 14th. The stock was sold at an average price of $134.01, for a total transaction of $161,348.04. Following the transaction, the chief financial officer now owns 2,664 shares in the company, valued at $357,002.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman V Gordon Clemons sold 1,000 shares of CorVel stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $165.59, for a total value of $165,590.00. Following the transaction, the chairman now owns 454,920 shares in the company, valued at approximately $75,330,202.80. The disclosure for this sale can be found here. Insiders have sold 69,906 shares of company stock worth $10,727,417 in the last three months. 48.56% of the stock is currently owned by insiders.

Receive CRVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CorVel and its competitors with MarketBeat's FREE daily newsletter.

CRVL Stock News Headlines

CorVel Co. (NASDAQ:CRVL) Chairman Sells $165,590.00 in Stock
Jean Macino Sells 76 Shares of CorVel Co. (NASDAQ:CRVL) Stock
CorVel (NASDAQ:CRVL) Rating Increased to B at TheStreet
CorVel (NASDAQ:CRVL) Lifted to B at TheStreet
CorVel (NASDAQ:CRVL) Upgraded at TheStreet
CorVel (NASDAQ:CRVL) Upgraded to "B" at TheStreet
See More Headlines
Receive CRVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CorVel and its competitors with MarketBeat's FREE daily newsletter.

CRVL Company Calendar

Last Earnings
8/02/2022
Today
8/09/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Insurance agents, brokers, & service
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:CRVL
CUSIP
22100610
Employees
4,233
Year Founded
N/A

Profitability

Net Income
$66.41 million
Pretax Margin
12.71%

Debt

Sales & Book Value

Annual Sales
$646.23 million
Cash Flow
$5.17 per share
Book Value
$12.05 per share

Miscellaneous

Free Float
9,027,000
Market Cap
$2.79 billion
Optionable
Optionable
Beta
0.95














CRVL Stock - Frequently Asked Questions

How has CorVel's stock price performed in 2022?

CorVel's stock was trading at $208.00 at the start of the year. Since then, CRVL shares have decreased by 23.6% and is now trading at $158.94.
View the best growth stocks for 2022 here
.

When is CorVel's next earnings date?

CorVel is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our CRVL earnings forecast
.

How were CorVel's earnings last quarter?

CorVel Co. (NASDAQ:CRVL) announced its earnings results on Tuesday, August, 2nd. The business services provider reported $0.94 EPS for the quarter. The business services provider earned $176.31 million during the quarter. CorVel had a trailing twelve-month return on equity of 30.93% and a net margin of 9.89%.

What is Michael Combs' approval rating as CorVel's CEO?

30 employees have rated CorVel Chief Executive Officer Michael Combs on Glassdoor.com. Michael Combs has an approval rating of 80% among the company's employees.

What other stocks do shareholders of CorVel own?

What is CorVel's stock symbol?

CorVel trades on the NASDAQ under the ticker symbol "CRVL."

Who are CorVel's major shareholders?

CorVel's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (1.36%), Victory Capital Management Inc. (0.20%), Assenagon Asset Management S.A. (0.15%), TD Asset Management Inc. (0.14%), Alphastar Capital Management LLC (0.12%) and Aviva PLC (0.08%). Insiders that own company stock include Alan Hoops, Brandon O'brien, Corstar Holdings Inc, Diane Blaha, Jean Macino, Jeffrey J Michael, Jennifer Yoss, Maxim Shishin, Michael G Combs, R Judd Jessup, Steven J Hamerslag and V Gordon Clemons.
View institutional ownership trends
.

How do I buy shares of CorVel?

Shares of CRVL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CorVel's stock price today?

One share of CRVL stock can currently be purchased for approximately $158.94.

How much money does CorVel make?

CorVel (NASDAQ:CRVL) has a market capitalization of $2.79 billion and generates $646.23 million in revenue each year. The business services provider earns $66.41 million in net income (profit) each year or $3.67 on an earnings per share basis.

How many employees does CorVel have?

CorVel employs 4,233 workers across the globe.

How can I contact CorVel?

CorVel's mailing address is 1920 Main Street Suite 900, Irvine CA, 92614. The official website for the company is www.corvel.com. The business services provider can be reached via phone at (949) 851-1473, via email at investor_relations@corvel.com, or via fax at 949-851-1469.

This page (NASDAQ:CRVL) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.